ESMO Lifetime Achievement Award

The Dutch Cancer Institute (NKI) has won the ESMO Lifetime Achievement Award, presented by The European Society for Medical Oncology, for its `excellent translational research into breast cancer´.

Photo: ESMO Lifetime Achievement Award

The NKI has bridged the field of molecular biological research and the clinic. In particular it has developed genetic assays for breast cancer that, according to ESMO, lead to better understanding of the disease and probably to more precise and less aggressive treatment.
The ESMO award – which includes ?50,000 for research - was presented for the second time; last year it went to the Breast International Group (BIG), a platform for clinical research into breast cancer.

Apologies instead of condolences
The wife of a patient, who had been treated in the ICU of the Medisch Spectrum Twente Hospital after receiving serious burns during a barbecue accident, received a questionnaire asking her to tell the hospital management about her experience with condolences she had received. The hospital letter arrived just as her husband arrived home. Its opening sentence read: ‘Recently your husband died in the intensive care ward….’ The hospital offered its apologies … better than condolences!

31.08.2007

More on the subject:

Related articles

Photo

News • Evolutionary dynamics of leukaemia

‘Fossil records’ let scientists trace AML back decades before diagnosis

Scientists have reconstructed how acute myeloid leukaemia (AML) develops over decades, showing that in many cases, first cancer-driving mutations are acquired more than 50 years before diagnosis.

Photo

News • Microgravity research

Cancer cells in space: quest to enhance chemotherapy effectiveness

Researchers are studying how microgravity affects how models of colorectal cancer cells respond to chemotherapy aboard the International Space Station. This could lead to new approaches on Earth.

Photo

News • Cardiac regeneration

Teaching the heart to heal itself after a heart attack

Scientists have developed an experimental treatment that ‘reawakens’ heart muscle cells after a heart attack so they start to repair damaged muscle. First results in mice show promising results.

Subscribe to Newsletter